Abstract:Uncovering the stimulus-response histories that give rise to cell fates and behaviors is an area of great interest in developmental biology, tissue engineering, and regenerative medicine. A comprehensive accounting of cell experiences that lead to the development of organs and tissues can help us to understand developmental anomalies that may underly disease. Perhaps more provocatively, such a record can also reveal clues as to how to drive cell collective decision-making processes, which may yield predictable cell-based therapies or facilitate production of tissue substitutes for transplantation or in vitro screening of prospective therapies to mitigate disease. Toward this end, various methods have been applied to molecularly trace developmental trajectories and record interaction histories of cells. Typical methods involve artificial gene circuits based on recombinases that activate a suite of fluorescent reporters or CRISPR-Cas9 genome writing technologies whose nucleic acid-based record keeping serves to chronicle cell-cell interactions or past exposure to stimuli of interests. Exciting expansions of the synthetic biology toolkit with artificial receptors that permit establishment of defined input-to-output linkages of cell decision-making processes opens the door to not only record cell-cell interactions, but to also potentiate directed manipulation of the outcomes of such interactions via regulation of carefully selected transgenes. Here, we combine CRISPR-based strategies to genetically and epigenetically manipulate cells to express components of the synthetic Notch receptor platform, a widely used artificial cell signaling module. Our approach gives rise to the ability to conditionally record interactions between human cells, where the record of engagement depends on expression of a state-specific marker of a subset of cells in a population. Further, such signal-competent interactions can be used to direct differentiation of human embryonic stem cells toward pre-selected fates based on assigned synNotch outputs. We also implemented CRISPR-based manipulation of native gene expression profiles to bias outcomes of cell engagement histories in a targeted manner. Thus, we present a useful strategy that gives rise to both state-specific recording of cell-cell interactions as well as methods to intentionally influence products of such cell-cell exchanges.

A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Spatiotemporal control of CRISPR/Cas9 gene editing

Multiplexed Genome Regulation in Vivo with Hyper-Efficient Cas12a

In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation

Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

CRISPR perfect adaptation for robust control of cellular immune and apoptotic responses

CRISPR-Based Genetic Switches and Other Complex Circuits: Research and Application

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

All-in-one AAV-delivered epigenome-editing platform: proof-of-concept and therapeutic implications for neurodegenerative disorders

Use of CRISPRoff and synthetic Notch to modulate and relay endogenous gene expression programs in engineered cells

Modulating CRISPR/Cas9 genome-editing activity by small molecules

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression

A revolutionary tool: CRISPR technology plays an important role in construction of intelligentized gene circuits

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model

An <i>in situ</i> cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a